|
with |
without |
t |
P |
Dry mouth |
62.15%±14.11% |
68.50%±15.09% |
0.970 |
0.341 |
Dry eye |
64.73%±10.86% |
66.74%±15.50% |
0.407 |
0.687 |
Decayed tooth |
53.60%±16.83% |
67.00%±9.81% |
2.671 |
0.013* |
Fatigue |
55.71%±17.50% |
67.54%±10.49% |
2.280 |
0.030* |
Arthralgia |
57.38%±14.24% |
69.69%±12.04% |
2.300 |
0.030* |
Skin involvement |
49.84%±18.09% |
66.30%±11.94% |
2.570 |
0.016* |
Gland involvement |
64.74%±11.84% |
65.90%±13.58% |
0.177 |
0.861 |
Leukocytopenia |
67.25%±11.54% |
64.18%±12.19% |
0.470 |
0.643 |
Raynaud’s phenomenon |
67.04%±10.45% |
64.05%±15.38% |
0.326 |
0.747 |
PBC |
49.00%±21.32% |
66.31%±12.64% |
2.316 |
0.028* |
ILD |
53.32%±17.57% |
67.78%±10.23% |
2.860 |
0.008** |
High IgG |
57.22%±15.95% |
70.85%±10.87% |
2.508 |
0.018* |
Anti-SSA/Ro52+
|
60.84%±15.21% |
62.89%±6.00% |
0.228 |
0.821 |
Anti-SSA/Ro60+
|
59.59%±15.25% |
76.34%±13.47% |
2.445 |
0.021* |
Anti-SSB+
|
57.96%±15.63% |
74.76%±11.06% |
3.029 |
0.005** |
Anti-centromere+
|
59.94%±14.83% |
70.72%±5.30% |
1.233 |
0.228 |
P< 0.05, **P < 0.01 |
*P< 0.05, **P < 0.01 |
*P< 0.05, **P < 0.01 |
*P< 0.05, **P < 0.01 |
*P< 0.05, **P < 0.01 |